Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart Peacock

Showing results (111-120 of 135) with videos related to

Pageof 14
Sort By:
BMC Cancer|July 2, 2025
What factors influence sexual and reproductive health care among adolescent and young adult cancer patients?: a novel serial focus group studyNiki Oveisi, Vicki Cheng, Dani Taylor, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 22, 2024
Evidence of Decreased Long-term Risk of Cervical Precancer after Negative Primary HPV Screens Compared with Negative Cytology Screens in a Longitudinal Cohort StudyAnna Gottschlich, Quan Hong, Lovedeep Gondara, et al.
Pediatric Blood & Cancer|June 29, 2010
Childhood, adolescent, and young adult cancer survivors research program of British Columbia: objectives, study design, and cohort characteristicsMary L McBride, Paul C Rogers, Sam B Sheps, et al.
Lancet Regional Health. Americas|October 3, 2023
Colposcopy referral rates post-introduction of primary screening with human papillomavirus testing: evidence from a large British Columbia cohort studyAnna Gottschlich, Lovedeep Gondara, Laurie W Smith, et al.
British Journal of Cancer|November 18, 2016
Disease detection and resource use in the safety and control arms of the HPV FOCAL cervical cancer screening trialAndrew J Coldman, Lovedeep Gondara, Laurie W Smith, et al.
JAMA|July 5, 2018
Effect of Screening With Primary Cervical HPV Testing vs Cytology Testing on High-grade Cervical Intraepithelial Neoplasia at 48 Months: The HPV FOCAL Randomized Clinical TrialGina Suzanne Ogilvie, Dirk van Niekerk, Mel Krajden, et al.
Breast Cancer Research and Treatment|June 9, 2016
Long-term cardiovascular outcomes and overall survival of early-stage breast cancer patients with early discontinuation of trastuzumab: a population-based studyInna Y Gong, Sunil Verma, Andrew T Yan, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 20, 2021
PET-Based Staging Is Cost-Effective in Early-Stage Follicular LymphomaAndrea C Lo, Lyndon P James, Anca Prica, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 16, 2012
Guidelines for health technologies: specific guidance for oncology products in CanadaNicole Mittmann, William K Evans, Angela Rocchi, et al.
International Journal of Cancer|June 28, 2019
Disease detection at the 48-month exit round of the HPV FOCAL cervical cancer screening trial in women per-protocol eligible for routine screeningAndrew J Coldman, Dirk van Niekerk, Mel Krajden, et al.
Pageof 14

Showing results (111-120 of 135) with videos related to

Sort By:
Pageof 14
BMC Cancer|July 2, 2025
What factors influence sexual and reproductive health care among adolescent and young adult cancer patients?: a novel serial focus group studyNiki Oveisi, Vicki Cheng, Dani Taylor, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 22, 2024
Evidence of Decreased Long-term Risk of Cervical Precancer after Negative Primary HPV Screens Compared with Negative Cytology Screens in a Longitudinal Cohort StudyAnna Gottschlich, Quan Hong, Lovedeep Gondara, et al.
Pediatric Blood & Cancer|June 29, 2010
Childhood, adolescent, and young adult cancer survivors research program of British Columbia: objectives, study design, and cohort characteristicsMary L McBride, Paul C Rogers, Sam B Sheps, et al.
Lancet Regional Health. Americas|October 3, 2023
Colposcopy referral rates post-introduction of primary screening with human papillomavirus testing: evidence from a large British Columbia cohort studyAnna Gottschlich, Lovedeep Gondara, Laurie W Smith, et al.
British Journal of Cancer|November 18, 2016
Disease detection and resource use in the safety and control arms of the HPV FOCAL cervical cancer screening trialAndrew J Coldman, Lovedeep Gondara, Laurie W Smith, et al.
JAMA|July 5, 2018
Effect of Screening With Primary Cervical HPV Testing vs Cytology Testing on High-grade Cervical Intraepithelial Neoplasia at 48 Months: The HPV FOCAL Randomized Clinical TrialGina Suzanne Ogilvie, Dirk van Niekerk, Mel Krajden, et al.
Breast Cancer Research and Treatment|June 9, 2016
Long-term cardiovascular outcomes and overall survival of early-stage breast cancer patients with early discontinuation of trastuzumab: a population-based studyInna Y Gong, Sunil Verma, Andrew T Yan, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 20, 2021
PET-Based Staging Is Cost-Effective in Early-Stage Follicular LymphomaAndrea C Lo, Lyndon P James, Anca Prica, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 16, 2012
Guidelines for health technologies: specific guidance for oncology products in CanadaNicole Mittmann, William K Evans, Angela Rocchi, et al.
International Journal of Cancer|June 28, 2019
Disease detection at the 48-month exit round of the HPV FOCAL cervical cancer screening trial in women per-protocol eligible for routine screeningAndrew J Coldman, Dirk van Niekerk, Mel Krajden, et al.
Pageof 14